ATOVAQUONE (Amneal Pharmaceuticals LLC)


Welcome to the PulseAid listing for the ATOVAQUONE drug offered from Amneal Pharmaceuticals LLC. This Antimalarial [EPC],Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amneal Pharmaceuticals LLC
NON-PROPRIETARY NAME: ATOVAQUONE
SUBSTANCE NAME: ATOVAQUONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimalarial [EPC],Antiprotozoal [EPC]
ROUTE: ORAL
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-02-09
END MARKETING DATE: 0000-00-00


ATOVAQUONE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionATOVAQUONE from Amneal Pharmaceuticals LLC
LABELER NAME: Amneal Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 750(mg/5mL)
START MARKETING DATE: 2011-02-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65162-693_7d24a3b4-d36a-4a57-bb17-64d825888ff2
PRODUCT NDC: 65162-693
APPLICATION NUMBER: ANDA202960

Other ATOVAQUONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals LLCATOVAQUONE
GlaxoSmithKline LLCMEPRON
Prasco LaboratoriesAtovaquone